Dimopoulos MA; Terpos E; Chanan-Khan A; Leung N; Ludwig H; Jagannath S; Niesvizky R; Giralt S; Fermand JP; Bladé J; Comenzo RL; Sezer O; Palumbo A; Harousseau JL; Richardson PG; Barlogie B; Anderson KC; Sonneveld P; Tosi P; Cavo M; Rajkumar SV; Durie BG; San Miguel J, Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group., «JOURNAL OF CLINICAL ONCOLOGY», 2010, 28, pp. 4976 - 4984 [articolo]
Morabito F; Gentile M; Ciolli S; Petrucci MT; Galimberti S; Mele G; Casulli AF; Mannina D; Piro E; Pinotti G; Palmieri S; Catalano L; Callea V; Offidani M; Musto P; Bringhen S; Baldini L; Tosi P; Di Raimondo F; Boccadoro M; Palumbo A; Cavo M., Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2010, 84 (3), pp. 223 - 228 [articolo]
Harousseau JL; Palumbo A; Richardson PG; Schlag R; Dimopoulos MA; Shpilberg O; Kropff M; Kentos A; Cavo M; Golenkov A; Komarnicki M; Mateos MV; Esseltine DL; Cakana A; Liu K; Deraedt W; van de Velde H; San Miguel JF., Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone., «BLOOD», 2010, 116, pp. 3743 - 3750 [articolo]
Ludwig H; Bolejack V; Crowley J; Bladé J; Miguel JS; Kyle RA; Rajkumar SV; Shimizu K; Turesson I; Westin J; Sonneveld P; Cavo M; Boccadoro M; Palumbo A; Tosi P; Harousseau JL; Attal M; Barlogie B; Stewart AK; Durie B., Survival and years of life lost in different age cohorts of patients with multiple myeloma., «JOURNAL OF CLINICAL ONCOLOGY», 2010, 28, pp. 1599 - 1605 [articolo]
Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucci A; Baccarani M; Cavo M., Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency., «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2010, 16, pp. 1115 - 1121 [articolo]
Cini M; Zamagni E; Valdré L; Palareti G; Patriarca F; Tacchetti P; Legnani C; Catalano L; Masini L; Tosi P; Gozzetti A; Cavo M, Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2010, 84, pp. 484 - 492 [articolo]
Perrone G; Hideshima T; Ikeda H; Okawa Y; Calabrese E; Gorgun G; Santo L; Cirstea D; Raje N; Chauhan D; Baccarani M; Cavo M; Anderson KC., Ascorbic acid inhibits antitumor activity of bortezomib in vivo, «LEUKEMIA», 2009, 23(9), pp. 1679 - 1686 [articolo]
Patriarca F; Petrucci MT; Bringhen S; Baldini L; Caravita T; Corradini P;
Corso A; Di Raimondo F; Falcone A; Ferrara F; Morabito F; Musto P; Offidani M; Petrini M; Rizzi R; Semenzato G; Tosi P; Vacca A; Cavo M; Boccadoro M; Palumbo A., Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2009, 82, pp. 93 - 105 [articolo]
Musto P; D'Auria F; Pietrantuono G; Baldini L; Bringhen S; Caravita T; Di Raimondo F; Morabito F; Offidani M; Petrucci MT; Tosi P; Gay F; Cavo M; Boccadoro M; Palumbo A., First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective., «CURRENT DRUG TARGETS», 2009, 10, pp. 906 - 922 [articolo]
Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG; International Myeloma Working Group., International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders., «LEUKEMIA», 2009, 23, pp. 215 - 224 [articolo]
Palumbo A; Sezer O; Kyle R; Miguel JS; Orlowski RZ; Moreau P; Niesvizky R; Morgan G; Comenzo R; Sonneveld P; Kumar S; Hajek R; Giralt S; Bringhen S; Anderson KC; Richardson PG; Cavo M; Davies F; Bladé J; Einsele H; Dimopoulos MA; Spencer A; Dispenzieri A; Reiman T; Shimizu K; Lee JH; Attal M; Boccadoro M; Mateos M; Chen W; Ludwig H; Joshua D; Chim J; Hungria V; Turesson I; Durie BG; Lonial S; IMWG, International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation., «LEUKEMIA», 2009, 23(10), pp. 1716 - 1730 [articolo]
Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Kumar S; Munshi NC; Dispenzieri A; Kyle R; Merlini G; San Miguel J; Ludwig H; Hajek R; Jagannath S; Blade J; Lonial S; Dimopoulos MA; Einsele H; Barlogie B; Anderson KC; Gertz M; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R;
Richardson PG; Niesvizky R; Rajkumar SV; Durie BG; IMWG., International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)., «LEUKEMIA», 2009, 23(10), pp. 1904 - 1912 [articolo]
Kumar S; Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Lentzsch S; Munshi N; Niesvizky R; San Miguel J; Ludwig H; Bergsagel L; Blade J; Lonial S; Anderson KC; Tosi P; Sonneveld P; Sezer O; Vesole D; Cavo M; Einsele H; Richardson PG; Durie BG; Rajkumar SV; International Myeloma Working Group., Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens., «BLOOD», 2009, 114(9), pp. 1729 - 1736 [articolo]
Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M., Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma., «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27(30), pp. 5001 - 5007 [articolo]
Rapezzi C; Merlini G; Quarta CC; Riva L; Longhi S; Leone O; Salvi F; Ciliberti P; Pastorelli F; Biagini E; Coccolo F; Cooke RM; Bacchi-Reggiani L; Sangiorgi D; Ferlini A; Cavo M; Zamagni E; Fonte ML; Palladini G; Salinaro F; Musca F; Obici L; Branzi A; Perlini S., Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types., «CIRCULATION», 2009, 13, pp. 1203 - 1212 [articolo]
